Showing results (21-30 of 168) with videos related to

Sort By:
Pageof 17
Antimicrobial Agents and Chemotherapy|July 31, 2025
Fractional curative killing of pyronaridine or artesunate combinations with tafenoquine, 4-aminoquinolines, or azithromycin in a murine malaria-luciferase modelGayoung Lee, Janessa Sochima Aneke, David J Sullivan
Molecular and Biochemical Parasitology|August 30, 2003
The shape and size of hemozoin crystals distinguishes diverse Plasmodium speciesGregory S Noland, Noelle Briones, David J Sullivan
Trends in Parasitology|April 13, 2010
An update on the rapid advances in malaria parasite cell biologyIsabelle Coppens, David J Sullivan, Sean T Prigge
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 16, 2019
Safety of Inactivated Influenza Vaccine in Cancer Patients Receiving Immune Checkpoint InhibitorsCurtis R Chong, Vivian J Park, Bevin Cohen, et al.
The Journal of Infectious Diseases|March 3, 2007
Plasmodium falciparum-infected erythrocytes decrease the integrity of human blood-brain barrier endothelial cell monolayersAbhai K Tripathi, David J Sullivan, Monique F Stins
Infection and Immunity|May 23, 2006
Plasmodium falciparum-infected erythrocytes increase intercellular adhesion molecule 1 expression on brain endothelium through NF-kappaBAbhai K Tripathi, David J Sullivan, Monique F Stins
Antimicrobial Agents and Chemotherapy|July 4, 2018
Superior Pyronaridine Single-Dose Pharmacodynamics Compared to Artesunate, Chloroquine, and Amodiaquine in a Murine Malaria Luciferase ModelWinter A Okoth, Elijah J Dukes, David J Sullivan
Antimicrobial Agents and Chemotherapy|November 20, 2013
Antimalarial efficacy of hydroxyethylapoquinine (SN-119) and its derivativesNatalie G Sanders, David J Meyers, David J Sullivan
The Journal of Antimicrobial Chemotherapy|August 20, 2009
In vitro activity of pyrvinium pamoate against Entamoeba histolytica and Giardia intestinalis using radiolabelled thymidine incorporation and an SYBR Green I-based fluorescence assayAutumn S Downey, Thaddeus K Graczyk, David J Sullivan
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|August 12, 2023
Analysis of SARS-CoV-2 mutations associated with resistance to therapeutic monoclonal antibodies that emerge after treatmentDaniele Focosi, Scott McConnell, David J Sullivan, et al.
Pageof 17